- TWD14.74bn
- TWD10.71bn
- TWD4.81bn
- 86
- 60
- 80
- 92
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 14.69 | ||
PEG Ratio (f) | 2.47 | ||
EPS Growth (f) | 6.33% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.72 | ||
Price to Tang. Book | 1.72 | ||
Price to Free Cashflow | 11.36 | ||
Price to Sales | 3.41 | ||
EV to EBITDA | 13.27 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.51% | ||
Return on Equity | 13.23% | ||
Operating Margin | 14% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | TWDm | 4,138.5 | 5,903.53 | 6,493.26 | 9,626.81 | 4,806.83 | 4,864 | 5,115 | 2.03% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -27.83 | +115.5 | +25.98 | +70.03 | -65.82 | -24.95 | +24.54 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Taidoc Technology Corp is a Taiwan-based company mainly engaged in the manufacture and sale of medical equipment. The main products include diagnostic testing instruments and reagents, home medical instruments, professional medical monitoring equipment and telemedicine products. The diagnostic test instruments include blood glucose monitors and blood glucose test chips, blood glucose measurement systems, glycated hemoglobin meters. The home medical instruments include ear thermometers, electronic sphygmomanometers, nebulizers. The professional medical monitoring equipment include equipment for monitoring changes in physiological parameters such as blood glucose, blood pressure, blood oxygen concentration, electrocardiogram and body temperature in hospitals and clinics. The telemedicine products include medical products with network connection functions. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Middle East and Asia.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- May 11th, 1998
- Public Since
- September 26th, 2008
- No. of Shareholders
- 15,920
- No. of Employees
- 829
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 95,374,000
- Address
- 6F, NEW TAIPEI, 248
- Web
- https://taidoc.com/
- Phone
- +886 266258188
- Contact
- Chun-Chieh Tseng
- Auditors
- Deloitte & Touche LLP
Upcoming Events for 4736
October 2024 Taidoc Technology Corp Corporate Sales Release
Q3 2024 Taidoc Technology Corp Earnings Release
November 2024 Taidoc Technology Corp Corporate Sales Release
December 2024 Taidoc Technology Corp Corporate Sales Release
January 2025 Taidoc Technology Corp Corporate Sales Release
February 2025 Taidoc Technology Corp Corporate Sales Release
Similar to 4736
Apex Biotechnology
Taiwan Stock Exchange
Wellell
Taiwan Stock Exchange
Bionime
Taiwan Stock Exchange
CHC Healthcare
Taiwan Stock Exchange
Excelsior Medical Co
Taiwan Stock Exchange
FAQ
As of Today at 23:34 UTC, shares in TaiDoc Technology are trading at TWD154.50. This share price information is delayed by 15 minutes.
Shares in TaiDoc Technology last closed at TWD154.50 and the price had moved by -0.64% over the past 365 days. In terms of relative price strength the TaiDoc Technology share price has underperformed the FTSE Developed Asia Pacific Index by -7.92% over the past year.
The overall consensus recommendation for TaiDoc Technology is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe TaiDoc Technology dividend yield is 6.47% based on the trailing twelve month period.
Last year, TaiDoc Technology paid a total dividend of TWD10.00, and it currently has a trailing dividend yield of 6.47%.Looking ahead, shares in TaiDoc Technology are due to go ex-dividend on 2024-09-09 and the next dividend pay date is 2024-10-04.
TaiDoc Technology are due to go ex-dividend on 2024-09-09 and the next dividend pay date is 2024-10-04. The historic dividend yield on TaiDoc Technology shares is currently 6.47%.
To buy shares in TaiDoc Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TWD154.50, shares in TaiDoc Technology had a market capitalisation of TWD14.74bn.
Here are the trading details for TaiDoc Technology:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 4736
Based on an overall assessment of its quality, value and momentum TaiDoc Technology is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in TaiDoc Technology is TWD150.00. That is 2.91% below the last closing price of TWD154.50.
Analysts covering TaiDoc Technology currently have a consensus Earnings Per Share (EPS) forecast of TWD8.99 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like TaiDoc Technology. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +0.82%.
As of the last closing price of TWD154.50, shares in TaiDoc Technology were trading -3.92% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The TaiDoc Technology PE ratio based on its reported earnings over the past 12 months is 14.69. The shares last closed at TWD154.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on TaiDoc Technology's directors